Increased number of high dose methotrexate cycles and the addition of rituximab is associated with better outcomes in a large primary CNSL cohort Meeting Abstract


Authors: Yerram, P.; Reiss, S. N.; Modelevsky, L.; Schaff, L.; Reiner, A.; Panageas, K.; Grommes, C.
Abstract Title: Increased number of high dose methotrexate cycles and the addition of rituximab is associated with better outcomes in a large primary CNSL cohort
Meeting Title: 61st Annual Meeting and Exposition of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 134
Issue: Suppl. 1
Meeting Dates: 2019 Dec 7-10
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2019-11-13
Language: English
ACCESSION: WOS:000577164602148
DOI: 10.1182/blood-2019-130349
PROVIDER: wos
Notes: Meeting Abstract: 4125 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anne S Reiner
    251 Reiner
  2. Christian Grommes
    153 Grommes
  3. Katherine S Panageas
    519 Panageas
  4. Samantha Nicole Reiss
    14 Reiss
  5. Lauren Rhea Schaff
    59 Schaff
  6. Prakirthi Yerram
    9 Yerram